Scienture Holdings, Inc. (SCNX)

↓ Download CSV

CIK 0001382574 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Scienture Holdings, Inc. reported revenue of $431.6K, up 215.9% from the prior year. The company ran a net loss, with a net margin of -9618.0% and a gross margin of 76.8%. It held $84.18M in total assets against $14.06M in total liabilities.

Key ratios (FY2025)

76.8%
Gross margin
-9867.9%
Operating margin
-9618.0%
Net margin
-59.2%
Return on equity
+215.9%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$431.6K$136.6K$1.36M$10.25M$9.89M$17.12M$7.44M$3.83M
Cost of Revenue$100.1K$130.6K$1.31M$4.73M$5.14M$11.42M$2.57M$449.0K
Gross Profit$331.5K$6.0K$49.0K$5.52M$4.75M$5.71M$4.87M$3.38M$2.93M$2.48M
Operating Income-$42.59M-$14.70M-$4.40M-$2.92M-$5.29M-$2.51M$125.2K-$87.6K$395.1K-$1.01M
Net Income-$41.51M$9.07M-$17.84M-$3.47M-$5.32M-$2.54M-$284.4K$9.0K$289.0K-$2.76M
EPS (Diluted)$-2.70$2.48$-23.35$-6.13$-0.65$-0.05$0.00$0.01$-0.09
Total Assets$84.18M$104.85M$12.53M$3.71M$5.77M$9.79M$5.57M$2.23M$617.5K$337.1K
Total Liabilities$14.06M$25.78M$11.99M$3.37M$2.00M$1.11M$1.43M$1.38M$929.4K$1.49M
Shareholders' Equity$70.12M$79.07M$542.4K$763.1K$3.77M$8.68M$4.14M$844.7K-$311.9K-$1.15M
Cash & Equivalents$6.66M$151.9K$1.09M$3.12M$5.92M$2.87M$869.6K$183.9K$14.7K
Operating Cash Flow-$13.38M-$14.27M-$2.23M-$1.53M-$2.57M-$2.21M$141.8K$273.4K$171.7K-$503.5K
Capital Expenditures$12.0K$22.6K$37.5K
Shares Outstanding40.63M8.75M905.0K626.2K8.17M8.09M6.54M5.55M31.99M31.66M